In No Rest for the Wicked, you will collect various items and resources to help you survive the harsh environment and fierce foes. Resources like Saltstone will allow you to upgrade your city, giving ...
Dec. 12 (Asia Today) - Taiwan Semiconductor Manufacturing Co., the world's largest contract chipmaker, is considering producing artificial intelligence-related semiconductors at its Kumamoto plant in ...
KANSAS CITY, Mo. — Kansas City International Airport is exploring adding international flights ahead of the 2026 FIFA World Cup, according to the Kansas City Aviation Department. Officials say they ...
The race to release world models is on as AI image and video generation company Runway joins an increasing number of startups and Big Tech companies by launching its first one. Dubbed GWM-1, the model ...
(CNN) — A new proposal from the US Food and Drug administration would allow sunscreens in the United States to include an active ingredient already commonly used in Europe, Australia and parts of Asia ...
The crew upgrades one of the world’s fastest airplanes, exploring the balance between engineering ambition and precision. New rift emerges in royal family – as members take sides in crunch talks ...
TORONTO — The Dodgers left Alex Vesia off the World Series roster they submitted on Friday morning and Manager Dave Roberts said Vesia “most likely” will miss the entire series. Vesia did not travel ...
October 24 - The Los Angeles Dodgers shuffled their bullpen while setting their World Series roster on Friday, hours ahead of Game 1 against the host Toronto Blue Jays. The Dodgers added right-handers ...
World of Warcraft Blizzard devs talk about going back to WoW's beloved expansion continent, Northrend, and rebuilding it for The Last Titan: 'We wanna make sure we're doing justice to those memories' ...
With World of Warcraft: Midnight, Blizzard is getting ready to make good on a major change to the game teased earlier this year: making some of the numerous mods, or add-ons, players love to use to ...
Genmab A/S is paying $8 billion to acquire Merus NV, gaining rights to the latter’s phase III-stage petosemtamab, a bispecific antibody initially in development for head and neck cancer, and ...